News

Fusion Pharmaceuticals Enters into Exclusive Worldwide License Agreement with Heidelberg University and Euratom for Actinium-Based PSMA Targeted Radiotherapy

View more

Mar 01, 2024

Blue Earth Therapeutics Announces Publication of Results from Independent Clinical Experience with 177Lu-rhPSMA-10.1 in Treatment of Metastatic Castrate Resistant Prostate Cancer

View more

Mar 01, 2024

Isotopia USA is thrilled to announce its new partnership with E Solutions and Comfort Systems USA to build out its North American headquarters and US GMP manufacturing center

View more

Feb 23, 2024

Radiopharmaceutical Therapy Controls Symptoms and Reduces Medications in Insulinoma Patients

View more

Feb 23, 2024

New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear

View more

Feb 23, 2024

64Cu-SAR-bisPSMA shows safety, efficacy in biochemically recurrent prostate cancer

View more

Feb 23, 2024